— Know what they know.
Not Investment Advice

MRVL vs ADI vs KLAC

161 measures in 16 categories, one definition each, computed from filings and market data.
MRVL67.0
Marvell Technology, Inc.
Technology · Semiconductors
$227.83 −5.56%$199.5B mkt cap
Score DNA
ADI81.4
Analog Devices, Inc.
Technology · Semiconductors
$395.44 −2.11%$191.6B mkt cap
Score DNA
KLAC72.1
KLA Corporation
Technology · Semiconductors
$165.74 −5.00%$216.3B mkt cap
Score DNA

Price, rebased to 100 three years ago

MRVL   ADI   KLAC   · weekly adjusted closes
100150200250300350400450500550600Jan 24Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26Oct 26MRVL 436KLAC 349ADI 242
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.

Smart money

8 measures
MeasureMRVLADIKLAC
Insider open-market buys, 180d 0 0 0
Insider $ bought, 180d — — —
Congress purchases, 180d 6 5 3
Last Congress purchase 2026-08-07 2026-10-08 2026-09-23
13F net change in holders — +171 +413
ETFs adding shares, 30d 1,835 1,794 1,859
ETFs trimming, 30d 1,492 1,461 1,478
Net ETF funds, 30d +343 +333 +381

Valuation

16 measures
MeasureMRVLADIKLAC
P/E (TTM) 75.6x
67th
46.3x
51st
44.8x
47th
PEG (P/E ÷ 3-yr EPS CAGR) — 8.01
100th
—
Price / sales 21.1x
88th
13.8x
72nd
15.9x
79th
Price / book 10.8x
73rd
5.7x
53rd
34.1x
100th
Price / tangible book 74.8x
96th
— 92.4x
97th
Price / free cash flow 115.3x
81st
38.8x
30th
57.4x
50th
Price / operating cash flow 90.7x
84th
34.6x
45th
52.2x
67th
Enterprise value $200.9B
87th
$198.4B
85th
$217.5B
88th
EV / sales 21.3x
89th
14.3x
75th
16.0x
79th
EV / EBITDA 42.2x
64th
28.2x
51st
35.9x
59th
EV / EBIT 57.5x
70th
39.3x
53rd
38.4x
51st
EV / free cash flow 116.1x
83rd
40.2x
30th
57.7x
52nd
Earnings yield 1.3%
55th
2.2%
65th
2.2%
68th
FCF yield 0.9%
41st
2.6%
79th
1.7%
64th
Operating cash flow yield 1.1%
35th
2.9%
65th
1.9%
48th
Graham number (per share) $36.02
56th
$113.95
94th
$19.91
23rd

Profitability (TTM)

12 measures
MeasureMRVLADIKLAC
Gross margin 51.4%
59th
65.8%
85th
61.3%
84th
EBITDA margin 50.3%
93rd
50.6%
95th
44.6%
91st
Operating margin 16.7%
65th
35.5%
92nd
41.7%
95th
EBIT margin 37.0%
91st
36.4%
89th
41.7%
95th
Net margin 27.9%
83rd
29.8%
85th
35.6%
95th
NOPAT margin 14.4%
65th
31.3%
89th
35.9%
95th
FCF margin 18.3%
69th
35.6%
93rd
27.7%
87th
Operating cash flow margin 23.3%
59th
39.9%
89th
30.5%
84th
R&D / revenue 25.8%
73rd
14.2%
40th
11.3%
28th
SG&A / revenue 8.8%
23rd
10.4%
29th
8.3%
20th
Stock comp / revenue 8.8%
71st
2.5%
39th
2.3%
33rd
Effective tax rate 13.7%
30th
12.1%
21st
13.8%
33rd

Returns on capital

11 measures
MeasureMRVLADIKLAC
ROE (on average equity) 16.5%
68th
12.2%
61st
87.5%
97th
ROA 11.0%
72nd
8.6%
63rd
28.4%
95th
ROIC 6.9%
48th
10.8%
55th
64.2%
92nd
ROCE 14.0%
69th
11.8%
68th
41.5%
96th
Return on tangible assets 14.5%
73rd
10.5%
65th
33.3%
95th
Cash ROIC (OCF / invested capital) 11.1%
38th
13.7%
48th
54.5%
96th
Gross profitability (GP / assets) 17.6%
37th
18.9%
44th
46.4%
93rd
ROIC, 3-yr average 0.2%
25th
6.6%
47th
80.7%
98th
ROIC, 5-yr average -0.8%
16th
6.9%
33rd
1,581.4%
100th
ROE, 5-yr average 0.6%
23rd
7.7%
34th
119.5%
100th
Incremental ROIC 25.8%
61st
— 80.1%
80th

Growth

17 measures
MeasureMRVLADIKLAC
Revenue growth (TTM YoY) 30.6%
70th
33.6%
74th
11.7%
38th
Revenue growth (QoQ) 13.3%
52nd
11.0%
40th
7.1%
21st
Revenue CAGR, 3 yr 18.9%
80th
2.6%
49th
9.0%
64th
Revenue CAGR, 5 yr 22.3%
76th
17.5%
73rd
14.4%
71st
Gross profit CAGR, 3 yr 24.3%
84th
2.6%
50th
9.9%
61st
Operating income CAGR, 3 yr — 5.1%
60th
12.3%
68th
Net income growth (TTM YoY) — 111.2%
73rd
18.9%
34th
Net income CAGR, 3 yr — 4.5%
59th
12.6%
67th
EPS growth (TTM YoY) — 114.0%
73rd
19.6%
37th
EPS CAGR, 3 yr — 5.8%
62nd
-47.0%
8th
EPS CAGR, 5 yr — 15.0%
61st
-22.9%
15th
FCF growth (TTM YoY) 13.1%
39th
34.2%
54th
0.6%
35th
FCF CAGR, 3 yr 31.2%
83rd
7.7%
56th
4.2%
51st
Operating cash flow CAGR, 3 yr 26.6%
78th
4.3%
56th
4.1%
52nd
Book value CAGR, 3 yr 4.0%
37th
-1.1%
21st
-39.0%
1st
Dividend CAGR, 3 yr -1.9%
11th
3.8%
63rd
-50.4%
0th
Sustainable growth rate 15.2%
62nd
6.2%
35th
68.3%
96th

Margin history & stability

7 measures
MeasureMRVLADIKLAC
Gross margin, 3-yr average 46.7%
49th
61.6%
86th
60.9%
85th
Operating margin, 3-yr average 3.3%
38th
28.0%
86th
40.4%
97th
Net margin, 3-yr average 2.7%
41st
23.0%
82nd
32.4%
94th
FCF margin, 3-yr average 22.0%
75th
33.8%
94th
29.8%
93rd
Revenue stability (0-1) 0.89
79th
0.57
49th
0.92
86th
Earnings stability (0-1) 0.38
54th
0.35
49th
0.73
81st
Margin stability (0-1) 0.94
57th
0.94
60th
0.99
99th

Liquidity (latest quarter)

7 measures
MeasureMRVLADIKLAC
Cash & short-term investments $3.9B
85th
$2.3B
77th
$4.9B
87th
Net cash (− = net debt) −$1.4B
13th
−$6.8B
7th
−$1.2B
15th
Working capital $5.4B
85th
$1.4B
64th
$8.1B
87th
Current ratio 3.17
44th
1.25
1st
2.88
37th
Quick ratio 2.62
51st
0.91
1st
2.03
37th
Cash ratio (cash + ST investments / current liabilities) 1.57
48th
0.41
7th
1.14
33rd
Defensive interval (days) 684 days
41st
410 days
17th
1,109 days
69th

Leverage & solvency (latest quarter)

13 measures
MeasureMRVLADIKLAC
Total debt $5.3B
85th
$9.1B
92nd
$6.2B
89th
Debt / equity 0.29
59th
0.27
56th
0.97
91st
Net debt / equity 0.07
72nd
0.20
79th
0.20
77th
Debt / assets 19.2%
63rd
18.8%
61st
34.3%
83rd
Debt / capital 22.2%
59th
21.4%
56th
49.2%
91st
Debt / EBITDA 1.11
47th
1.30
55th
1.02
44th
Net debt / EBITDA 0.28
74th
0.97
84th
0.21
72nd
Interest coverage (EBIT / interest) 16.2x
59th
14.4x
57th
19.9x
65th
Cash interest coverage 10.2x
37th
15.8x
54th
14.6x
48th
Debt payback (years of OCF) 2.4 yrs
67th
1.6 yrs
59th
1.5 yrs
55th
Liabilities / assets 32.7%
53rd
30.7%
49th
64.6%
95th
IS credit model rating AA AA- AA
Implied credit spread (bps) 80
19th
100
39th
80
19th

Efficiency

11 measures
MeasureMRVLADIKLAC
Asset turnover 0.39
23rd
0.29
15th
0.80
85th
Fixed asset turnover 6.94
68th
4.14
41st
9.84
87th
Inventory turnover 3.8
83rd
2.7
52nd
1.5
10th
Receivables turnover 5.1
29th
7.0
63rd
5.3
32nd
Days sales outstanding 71 days
71st
52 days
37th
69 days
68th
Days inventory outstanding 96 days
17th
136 days
48th
238 days
90th
Days payables outstanding 56 days
67th
45 days
39th
38 days
23rd
Cash conversion cycle (days) 111 days
35th
142 days
59th
270 days
93rd
Capex / revenue 5.0%
55th
4.4%
47th
2.8%
28th
Capex / depreciation 0.37
16th
0.31
12th
0.95
54th
Operating expense ratio 36.5%
59th
27.2%
35th
18.9%
20th

Cash flow & earnings quality

7 measures
MeasureMRVLADIKLAC
Operating cash flow / net income 0.83
21st
1.34
50th
0.86
23rd
FCF / net income 0.66
21st
1.19
69th
0.78
44th
FCF / operating cash flow 78.6%
58th
89.0%
79th
90.9%
88th
Capex / operating cash flow 21.4%
42nd
11.0%
21st
9.1%
12th
Accruals ratio 1.8%
77th
-2.9%
57th
4.0%
89th
Sloan accruals ratio 8.5%
65th
-9.3%
7th
6.3%
60th
Earnings quality score (0-1) 0.75
15th
1.00
77th
0.75
15th

Dividends & buybacks

9 measures
MeasureMRVLADIKLAC
Dividend yield 0.1%
67th
1.1%
87th
0.5%
76th
Dividend per share (TTM) $0.24
65th
$4.29
97th
$0.84
81st
Payout ratio (dividends / net income) 7.9%
56th
49.4%
87th
21.9%
69th
Dividends / FCF 12.1%
63rd
41.4%
83rd
28.1%
74th
Dividend growth (YoY) -4.6%
11th
9.3%
59th
17.6%
81st
Buyback yield 1.0%
76th
1.6%
85th
1.1%
80th
Shareholder yield (dividends + buybacks) 1.1%
63rd
2.7%
83rd
1.5%
71st
Share count change (YoY) 5.8%
74th
-1.3%
12th
-0.6%
16th
Buybacks, last 5 years $6.3B
87th
$12.4B
93rd
$10.7B
92nd

Scores & forensic checks

15 measures
MeasureMRVLADIKLAC
IS score 67
68th
81
95th
72
73rd
IS profitability 59
65th
78
79th
98
95th
IS growth 77
75th
77
71st
71
58th
IS value 37
53rd
38
57th
40
69th
IS momentum 87
68th
100
95th
76
44th
IS risk (safety) 100
12th
100
12th
100
12th
IS quality 73
61st
87
93rd
80
71st
IS balance sheet 85
52nd
68
27th
84
44th
IS earnings quality 61
40th
77
91st
57
36th
IS cash flow 58
49th
88
93rd
67
63rd
Piotroski F-score (0-9) 7
65th
7
65th
7
65th
Altman Z-score 12.6
51st
8.3
43rd
23.2
72nd
Beneish M-score −1.95
74th
−2.19
62nd
−2.03
70th
Ohlson O-score −10.58
28th
−10.53
31st
−8.99
55th
IS credit score 85
63rd
83
59th
87
67th

Per share

7 measures
MeasureMRVLADIKLAC
EPS, diluted (TTM) $2.87
73rd
$8.43
91st
$3.66
77th
Book value per share $20.12
59th
$68.43
96th
$4.81
8th
Tangible book per share $2.58
19th
−$3.91
5th
$3.28
23rd
Revenue per share $10.26
37th
$28.31
81st
$10.29
39th
FCF per share $1.88
56th
$10.07
93rd
$2.85
72nd
Operating cash flow per share $2.39
51st
$11.31
92nd
$3.14
63rd
Cash per share $4.27
28th
$4.74
36th
$3.71
19th

Size (TTM)

8 measures
MeasureMRVLADIKLAC
Market cap $199.5B
87th
$191.6B
85th
$216.3B
88th
Revenue $9.5B
81st
$13.9B
87th
$13.6B
85th
EBITDA $4.8B
84th
$7.0B
89th
$6.1B
88th
Net income $2.6B
84th
$4.1B
88th
$4.8B
89th
Free cash flow $1.7B
81st
$4.9B
91st
$3.8B
88th
Total assets $27.6B
88th
$48.4B
92nd
$18.0B
81st
Shareholders' equity $18.5B
89th
$33.6B
93rd
$6.3B
75th
Employees 7,480
68th
24,500
84th
17,100
77th

Price performance

9 measures
MeasureMRVLADIKLAC
1 day −5.6% −2.1% −5.0%
1 week −17.2% −2.6% −15.2%
1 month −5.4% +9.0% −1.9%
3 months +16.9% +6.5% −20.1%
6 months +63.1% +7.1% −7.3%
Year to date +155.0% +45.8% +30.5%
1 year +156.3% +68.1% +53.3%
3 years, cumulative +316.1% +136.9% +251.7%
5 years, cumulative +258.3% +154.9% +433.8%

Technicals

4 measures
MeasureMRVLADIKLAC
RSI 14 37.5 49.7 31.1
From 52-week high −30.9% −11.1% −46.0%
From 52-week low +222.3% +79.2% +55.2%
Beta 2.26 1.23 1.45
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms